72 Participants Needed

Supervised Exercise for Transplant Recipients

JR
Overseen ByJacqui Rick
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Abramson Cancer Center of the University of Pennsylvania
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests whether a supervised exercise program can benefit individuals undergoing allogeneic HCT, a type of bone marrow transplant. The study consists of two parts: one for participants who begin exercising before their transplant and another for those who start after their initial hospital stay. The goal is to determine if these exercise programs are feasible and beneficial for patients. This trial may suit individuals aged 60 or older with blood cancer, planning for a transplant soon, and experiencing increased difficulty with everyday activities. As an unphased trial, it offers a unique opportunity to contribute to research that could enhance recovery and quality of life for future transplant patients.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It focuses on a supervised exercise program for transplant recipients.

What prior data suggests that this exercise program is safe for transplant recipients?

Research shows that exercise programs are generally safe for individuals who have undergone a hematopoietic stem cell transplant (HSCT). Studies have found that these activities can improve physical health without causing harm. For example, one study found that supervised exercise programs, similar to those in cardiac rehabilitation, are well-tolerated even by individuals with serious health conditions, such as heart transplants.

Other research confirms that exercise is safe for HSCT recipients and can enhance physical abilities and overall quality of life. Additionally, evidence indicates that exercise is not only safe but also beneficial for individuals with blood-related cancers.

In summary, these findings suggest that participating in a supervised exercise program with professional guidance is safe and beneficial for transplant recipients.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores how tailored exercise programs can benefit transplant recipients before and after their procedures. Unlike typical recovery protocols that might not emphasize structured physical activity, this trial investigates supervised exercise both as a preparatory step (Prehab) and as rehabilitation (Rehab) after transplant. The Prehab program aims to strengthen patients even before they undergo hematopoietic cell transplantation (HCT), potentially improving outcomes. Meanwhile, the Rehab program focuses on maintaining and enhancing physical function post-transplant, especially in older adults. By examining these structured exercise regimens, researchers hope to uncover new ways to boost recovery and quality of life for transplant patients.

What evidence suggests that this exercise program is effective for transplant recipients?

Research has shown that exercise programs can greatly enhance fitness and quality of life for transplant recipients. One study found that patients in these programs improved their fitness levels by 16% to 25%. In this trial, participants will be divided into two cohorts: Cohort A (Prehab) and Cohort B (Rehab). Cohort A will engage in a supervised exercise program before their hematopoietic stem cell transplant (HSCT), while Cohort B will begin their exercise program after discharge from their initial hospital stay for HSCT. Exercise also reduces tiredness and enhances overall well-being. For patients who have undergone an HSCT, exercise helps maintain physical activity and may improve survival chances post-transplant. Strength training, in particular, prevents muscle loss and reduced activity. Overall, evidence supports that exercise positively impacts recovery and quality of life for transplant recipients.23678

Who Is on the Research Team?

SM

Shannon McCurdy, MD

Principal Investigator

Penn Medicine

Are You a Good Fit for This Trial?

This trial is for older adults (60+) who are either pre-frail or frail and are planning to undergo or have undergone an allogeneic hematopoietic cell transplant (HCT) due to a blood cancer. Participants will be split into two groups: one that starts the exercise program before HCT and another that begins after HCT.

Inclusion Criteria

I am 60 or older, planning a stem cell transplant due to blood cancer, and considered pre-frail or frail.
I am 60 or older, had or planning a stem cell transplant for blood cancer.

Exclusion Criteria

Cohorts A and B: Comorbid disability or illness that prevents safe exercise

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Prehabilitation

Pre-frail and frail subjects attend at least twice weekly exercise sessions with a physical therapist and complete an exercise program at home prior to admission for HCT

4-6 weeks
At least 2 visits per week (in-person)

Rehabilitation

All patients 60 years and older attend at least weekly exercise sessions with a physical therapist and complete an exercise program at home through Day +100 after HCT

14 weeks
At least 1 visit per week (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Exercise Program (Cohort A Prehab)
  • Exercise Program (Cohort B Rehab)
Trial Overview The study is testing if a supervised exercise program can improve health outcomes for those receiving allogeneic HCT. It's a pilot study, meaning it's preliminary research to see if the idea is feasible. Subjects will be divided into two cohorts based on when they start exercising relative to their transplant procedure.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Group I: Cohort B (Rehab)Experimental Treatment1 Intervention
Group II: Cohort A (Prehab)Experimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Abramson Cancer Center of the University of Pennsylvania

Lead Sponsor

Trials
360
Recruited
108,000+

Abramson Cancer Center at Penn Medicine

Lead Sponsor

Trials
425
Recruited
464,000+

Published Research Related to This Trial

Cardiac rehabilitation programs are generally safe and effective for improving the functional activities of patients with cardiac disease, but not all patients require supervised rehabilitation, especially those who were active before their cardiac event.
High-risk patients with low functional capacities (3-5 METs) benefit the most from rehabilitation, while low-risk patients (7-9 METs) may not need the program, indicating that rehabilitation should be tailored based on individual physical and psychological conditions.
Cardiac rehabilitation programs.Hotta, SS.[2010]
Eighteen lung transplant recipients, averaging 52 years old, participated in a qualitative study that highlighted their strong desire to regain normalcy in daily life through supervised exercise rehabilitation, which they found essential for their recovery.
The study revealed that group exercise sessions provided motivation and peer support, significantly enhancing the rehabilitation experience, although some patients faced limitations due to pre-existing or postoperative health issues.
Patients' expectations and experiences of rehabilitation following lung transplantation.Fuller, LM., Button, B., Tarrant, B., et al.[2014]
This systematic review aims to evaluate the benefits and harms of prehabilitation programs, primarily focused on physical exercise, for cancer patients compared to standard care, highlighting the potential for improved clinical outcomes such as aerobic capacity and reduced postoperative complications.
The review will utilize rigorous methods, including independent screening of studies and quality assessments, to ensure reliable results that can guide healthcare providers and patients in making informed decisions about prehabilitation in cancer care.
Prehabilitation programs for cancer patients: a systematic review of randomized controlled trials (protocol).Meneses-Echávez, JF., Loaiza-Betancur, AF., Díaz-López, V., et al.[2023]

Citations

IMPROVE-BMT: A Pilot Randomized Controlled Trial of ...Overall, exercise adherence across all patients, regardless of transplant type, was high at an average of 91.98% (SD = 34.59), ranging from 33% ...
Randomized controlled trial on the effects of a supervised high ...Median improvements in physical fitness ranged between 16 and 25% in the intervention group and between 12 and 19% in the control group. Fatigue decreased in ...
Supervised Exercise for Transplant RecipientsResearch shows that exercise programs can improve physical fitness, quality of life, and functional mobility in liver transplant recipients. Additionally, ...
Effectiveness of Physical Exercise on Hematopoietic Stem ...Physical exercise benefits HSCT patients by improving quality of life and reducing fatigue. Evidence quality is moderate to critically low, requiring cautious ...
Exercise in Patients Receiving Hematopoietic Stem Cell ...Strength training may be an effective intervention to alleviate problems with decreased physical activity, reduced muscle mass, and fatigue in HSCT recipients.
Improve Outcomes for Older Allogeneic Transplant ...This is an interventional pilot study to determine whether implementation of a supervised exercise program can improve outcomes in subjects undergoing ...
the Active Care after Transplantation (ACT) multicentre ...Safety outcomes showed no safety concerns. After 3 months of supervised exercise intervention, HRQoL-domain physical functioning improved in ...
Prehabilitative high-intensity interval training and ...Evidence suggests that exercise interventions in patients with haematological cancer are safe and beneficial.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security